Insiders · XBIT

Peter Libby

Director at XBiotech Inc. (XBIT)

Peter Libby has filed 6 insider reports with the SEC since April 2021, as director at XBiotech Inc. (XBIT). The latest filing, on June 21, 2024, reports grant or award at XBiotech Inc. (XBIT).

Filings
6
Companies
1
Bought on market
None
Sold on market
None

Companies where Peter Libby is an insider

CompanyRoleShares heldBoughtSoldAvg buyPrice nowLast filing
XBiotech Inc. logo
XBIT
XBiotech Inc.
Director25,000$1.73Jun 21, 2024

Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.

Every filing

Compare Peter Libby with

Other insiders at the same companies

Questions about Peter Libby

What is Peter Libby's role at XBiotech Inc.?
Peter Libby reports to the SEC as director at XBiotech Inc. (XBIT), according to the latest filing on June 21, 2024.
How many shares does Peter Libby own?
After the latest filing that states it, Peter Libby directly owned 25,000 shares of XBiotech Inc. (XBIT). Shares held through trusts, funds or family members are reported separately and are not counted here.
Has Peter Libby bought or sold stock recently?
No open-market purchases or sales by Peter Libby are on file. The filings report grant or award and exercise or conversion of a derivative.
How do I get alerts when Peter Libby files?
Follow Peter Libby on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.

From SEC Forms 3, 4, 5 and 144 filed by Peter Libby (SEC CIK 0001784088). Totals count each trade once, skipping amendments whose original is on file, from Apr 27, 2021 on. View on SEC EDGAR